logo
Share SHARE
FONT-SIZE Plus   Neg

Amgen Reports Top-Line Results Of Phase 3 Sensipar/Mimpara EVOLVE Trial

Amgen Inc. (AMGN: Quote) announced top-line results of the Phase 3 EVOLVE trial, evaluating Sensipar/Mimpara for the reduction of the risk of mortality and cardiovascular or CV events among 3,883 patients with secondary hyperparathyroidism and chronic kidney disease receiving dialysis.

The trial's primary endpoint was time to the composite event comprising all-cause mortality or first non-fatal cardiovascular event, including myocardial infarction, hospitalization for unstable angina, heart failure or peripheral vascular event. Though patients in the Sensipar/Mimpara arm experienced numerically fewer composite primary events, the results were not statistically significant, and the study failed to meet its primary endpoint in the intent-to-treat analysis.

"Amgen embarked on the EVOLVE trial to understand whether treating secondary HPT with Sensipar/Mimpara could positively impact the high rates of mortality and cardiovascular events among patients with CKD receiving dialysis," said Sean Harper, M.D., executive vice president of Research and Development at Amgen.

The most frequently reported adverse events in the Sensipar/Mimpara arm of the trial were consistent with the known safety profile of this therapy and included nausea, vomiting and hypocalcemia.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Snapchat created a furor after dropping the Best Friends feature which allowed users to see who their contacts had been sharing snaps with the most. But the ephemeral messaging service provider soon vowed to reinstate the feature to assuage users who said Best Friends helped them ensure fidelity. Chinese e-commerce giant Alibaba reported a 28 percent drop in third-quarter profit, hurt by stock-based compensation expense and other costs. Meanwhile revenues surged 40 percent, driven by growth in China commerce retail business, though not at the rate analysts expected, even as its active user base ballooned. Alibaba shares dropped 9% on the NYSE. McDonald's has announced its Chief Executive Office Don Thompson will be "retiring" at the age of 51, after two tumultuous years on the job. It will instead be up to Steve Easterbrook, 48, McDonald's chief brand officer, to reverse a downturn in fortunes for the iconic hamburger chain. His challenges...
comments powered by Disqus
RELATED NEWS
Trade AMGN now with 
Follow RTT